Ivan Mac

[Ivan Mac @IvanmacMac]

@avidresearch @given2tweet TACO

[Ivan Mac @IvanmacMac]

@Pharmdca I agree, you picked the wrong worst candidate

[Ivan Mac @IvanmacMac]

@A_May_MD @T36462509 They also forgot uveitis. (Large potential to treat chronic eye inflammation)

[Ivan Mac @IvanmacMac]

@WallStAction @A_May_MD Look at Pelage PP-405 for that

[Ivan Mac @IvanmacMac]

@given2tweet Oil prices permanently higher. Has to price in new risk premium.

[Ivan Mac @IvanmacMac]

@rn1investor @powerstocks I agree. Hopefully she is not blowing smoke up everyone’s a$$es. If a deal comes to fruition, exponential return possibilities. Slowly accumulating shares here. Now up to 130,000

[Ivan Mac @IvanmacMac]

@rn1investor @powerstocks Yes, but painful to wait for news of advancement into Phase 3 with hopefully, a partnership.

[Ivan Mac @IvanmacMac]

@A_May_MD @grok Pelage PP405 with much different MOA and safety will own the hair loss market.

[Ivan Mac @IvanmacMac]

@be4_the_h3rd This is Trump’s own Fed chair.

[Ivan Mac @IvanmacMac]

@Biotech_AI @pawcio2009 You got it. This is a redo trial and was redesigned to mitigate problem with 1st Phase 3. Should hit.if works, any disease state that benefits from steroids is a candidate for their technology.

[Ivan Mac @IvanmacMac]

@Biotech_AI @pawcio2009 February readout for Phase 3 for Ataxia Telangiectasia.

[Ivan Mac @IvanmacMac]

@Biotech_AI @pawcio2009 Encapsulates steroids for sustained release on RBCs. Steroid efficacy for multiple diseases and eliminated steroid toxicity. Platform in a product $qncx.

[Ivan Mac @IvanmacMac]

@Biotech_AI @pawcio2009 $cmmb also my pick. Alternate was $qncx

[Ivan Mac @IvanmacMac]

@given2tweet How about that Trump fusion company merger announcement. The grift is endless

[Ivan Mac @IvanmacMac]

@DrMakaryFDA And sydnexis

[Ivan Mac @IvanmacMac]

@bijans @matthewherper These Medicare cuts are beyond ridiculous. All specialties have been hammered for years. Many practices can no longer afford to see Medicare patients at these reimbursement rates. Yet, executive pay packages through the roof.

[Ivan Mac @IvanmacMac]

@Se19edy @anthonystaj Anyone have thoughts on Pelage’s PP-405 in AA? Seems to work well for androgenic alopecia.

[Ivan Mac @IvanmacMac]

@millanpatel @SuperDuperInvst There is no approved treatment for PSC and nothing has ever shown data that nebokitug did in Phase 2. This is an asymmetric risk/reward opportunity. FDA in alignment of Phase 3 registration trial. CEO stated they will advance to Phase 3 with partner or (possibly buyout)

[Ivan Mac @IvanmacMac]

@SuperDuperInvst Read thread by @ErikOtto2 on $cmmb. Tells you all you need for due diligence. I own 2% of company, he owns over 5%

[Ivan Mac @IvanmacMac]

@SuperDuperInvst $cmmb. $18 million market cap. $1.5 billion/year opportunity in primary biliary sclerosis. Supposed to start Phase 3 (very strong Phase 2 data). Partnership/buyout any day now